We anticipate the future in order to better serve an increasingly demanding market in its control processes, standards and parameters.
Conceived and founded by professionals who together have built a success story in the global aesthetic medicine market with the brand of polylactic acid threads (Silhouette Soft) - Silhouette Lift, present in more than 60 countries, sold in 2014 to the British company Sinclair IS Pharma SA.
Pharmaesthetics, a company based in Luxembourg, was created to meet the need of professionals looking for products that combine technology, safety and efficacy - enabling healthcare professionals to work while respecting and recovering the characteristics of each patient, whether aesthetic or therapeutic.
We are a company dedicated to well-being. We constantly study and develop new technologies to achieve our great goal, our reason for existing - to raise the self-esteem, well-being and satisfaction of as many people as possible.
We are committed to health professionals and their patients.
We work tirelessly to ensure the efficacy and safety of our products, always with scientific proof, using and creating the most modern technologies. We are above and in line with global quality, safety and environmental standards.
Pharmaesthetics is proud to be the first Brazilian laboratory to produce cross-linked Hyaluronic Acid in different concentrations, with or without lidocaine, and to offer a portfolio of reliable products in aesthetic and therapeutic solutions, using the best raw materials in the world with the know-how of international professionals who have been in this segment for over 20 years.
Founder, President and CEO of Lancelot Investments S.A. parent company of Pharmaesthetics Group do Brasil. Mr. Capinan has a solid background in distribution, doing important work for Silhouette Lift Inc. His company accounted for 50% of Silhouette Lift's global sales, which was sold to a publicly traded British pharmaceutical company in 2014. He has a degree in Mechanical Engineering with a specialization in Robotics from the University of São Paulo (USP).
Founder and Chairman of the Board of Lancelot Investments S.A., parent company of Pharmaesthetics Group do Brasil. Mr. Schupak has extensive experience and knowledge in the field of aesthetics acquired through the successful launch of Silhouette Lift. He was the founder and CEO of Silhouette Lift, a company that achieved success in more than 60 countries until its acquisition in 2014 by Sinclair Pharma SA, a British publicly traded company.
Senior Advisor at Lancelot Investment S.A., the parent company of Pharmaesthetics Group Brazil, and also co-founder and board member of Kartesia, one of the leading pan-European investment managers in private debt and private equity. Before founding Kartesia in 2013, Laurent co-founded the Altercap Funds at LBO France, where he successfully raised and invested €500 million in corporate credit opportunities. He began his career at Crédit Agricole CIB (formerly Crédit Agricole Indosuez), where he initially worked in project finance within the telecommunications sector.
Industrial Pharmacist and Lawyer, specialist in Regulatory Affairs with over 30 years' experience in the pharmaceutical industry in the areas of Regulatory Affairs (Regulatory Affairs and CMC), including biological products and vaccines, Quality Control, Quality Assurance and New Product Development. He has expertise in new projects/PDP's (Productive Development Partnerships) and extensive experience in audits, including international ones.
He graduated in Economics and Business Administration from Insper, with a specialization in Corporate Finance from the Wharton School at the University of Pennsylvania. Felipe pursued a career in the financial market, where he specialized in corporate transactions and company restructuring. He also worked in the credit area at Banco Safra and in asset management companies, where he led strategic initiatives and identified growth opportunities in key sectors.
With extensive experience in strategy, branding, and integrated communication, Ana Lucia Paixão built her career leading marketing departments in major companies across different sectors, including Telecommunications, Retail, Banking, and the Luxury Market. She currently heads the Marketing Department at Pharmaesthetics Brazil, where she leads the brand’s strategic positioning and product development in a highly competitive market. Her work has been essential in building Pharmaesthetics’ institutional identity, strengthening its national presence, and repositioning the brand as a reference in science, technology, and advanced aesthetics.
Graduated from Mackenzie and post-graduated from FGV (Fundação Getúlio Vargas). Professional with solid experience in the pharmaceutical industry, in medium to large-sized companies, both national and multinational. Strong performance in the corporate market, prospecting and opening clients and commercial strategies. Excellent relationship in the national market with renowned professionals, thus achieving significant goals and results. Experience in management, motivation and team skills training.
With extensive experience in relationship management and customer service in the health and aesthetics sector, she has the ability to create and maintain solid partnerships, promoting efficient communication and ensuring customer satisfaction. Her collaborative and results-oriented approach contributes significantly to the company's growth by developing customized solutions for clients' needs.
Graduated from Universidade 9 de Julho in Pharmaceutical Product Advertising, with over 25 years' experience in the Brazilian market, responsible for marketing fillers, bio-stimulators, support threads, botulinum toxin, breast prostheses and technologies, contributing significantly to the growth of this category in the main national and multinational companies in the segment. Experience in developing and managing sales teams.
